Remove tag biotechnology
article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

Australian biotechnology company Cartherics has granted licence for CTH-004 , its autologous CAR-T cell product, to Chinese company Shunxi. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP. In animal models of ovarian cancer, it demonstrated promising results.

article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. Prior to his role at Tubulis, Jonas gained 10 years of field experience, deepening his knowledge of biotechnology and antibody engineering. Tubulis’ second technology platform is called Tub?tag

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CEPI provides $30m to advance novel coronavirus vaccine

European Pharmaceutical Review

Manufacturing efforts for the project will be led by the UK’s Centre for Process Innovation ( CPI ) using microbes engineered by biotechnology Ingenza Ltd. These coronavirus RBDs are attached to a nanoparticle by protein tags, enabling the structure to display fragments from multiple viruses on a single nanoparticle. .

article thumbnail

Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

PM360

This option grows more critical as new therapies become available with price tags as high as $3.5 Biotechnology Innovation Organization, February 16, 2021. Many new solutions allow the high one-time costs of gene therapies and other expensive medication to be converted into small, predictable payments over time for payers.